Posted on May 4, 20265/4/26
Scaling Innovation Without Losing Executional Rigor: Q&A with Mark Thierer
Posted on April 28, 20264/28/26
4 Takeaways from Google Cloud’s NEXT 2026 and what’s on the horizon for pharma
Posted on April 23, 20264/23/26
Driving Innovation in Specialty Pharmacy: Q&A Gregory Skalicky from EVERSANA Ahead of Asembia 2026
Posted on April 20, 20264/20/26
Reimagining Annual Brand Planning with AI
Posted on April 15, 20264/15/26
A New Standard for Copay Excellence: Q&A with Brian Laird
Posted on March 17, 20263/17/26
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
Posted on March 16, 20263/16/26
Why women’s health is at an inflection point and why commercialization models must advance
Posted on February 26, 20262/26/26
Building a scalable GLP-1 care model
Posted on February 26, 20262/26/26
Creative matters: Connecting with the rare disease community
Posted on February 18, 20262/18/26